Vapreotide - Revision history

Prab: CSV import

2025-02-20T01:16:25Z

CSV import

← Older revision		Revision as of 01:16, 20 February 2025
Line 41:		Line 41:
	[[Category:Somatostatin analogs]]		[[Category:Somatostatin analogs]]
	[[Category:Endocrinology]]		[[Category:Endocrinology]]
			<gallery>
			File:Vapreotide.svg\|Vapreotide
			</gallery>

Prab: CSV import

2025-02-13T03:54:55Z

CSV import

← Older revision		Revision as of 03:54, 13 February 2025
Line 1:		Line 1:
	{{Short description\|~~Synthetic~~ somatostatin analog}}		{{Short description\|A synthetic somatostatin analog used in medicine}}
	{{~~Use dmy dates~~\|~~date~~=~~October 2023}}~~		{{Drugbox
	~~[[File:~~Vapreotide.svg\|~~thumb\|Chemical structure of Vapreotide]]~~		\| verifiedfields = changed
	'''Vapreotide''' is a synthetic [[somatostatin]] analog used primarily in the treatment of certain ~~types of~~ [[~~cancer~~]] and [[~~gastrointestinal~~]] ~~disorders~~. It mimics the action of natural somatostatin, a hormone that inhibits the release of several other hormones and secretions in the body.		\| verifiedrevid = 477002123
			\| image = Vapreotide.svg
			\| image2 = <!-- Another image if available -->
			}}

			'''Vapreotide''' is a synthetic [[somatostatin]] analog used primarily in the treatment of certain medical conditions such as [[esophageal varices]] and [[acromegaly]]. It mimics the action of natural somatostatin, a hormone that inhibits the release of several other hormones and secretions in the body.

	==Pharmacology==		==Pharmacology==
	Vapreotide ~~is a [[cyclic peptide]] that acts as an agonist at~~ somatostatin receptors~~. It has a high affinity for~~ the ~~[[somatostatin receptor]] subtypes 2, 3, and 5~~. By binding ~~to these receptors, vapreotide~~ inhibits the secretion of [[growth hormone]], [[insulin]], and [[glucagon]].		Vapreotide functions by binding to somatostatin receptors, which are G-protein-coupled receptors found throughout the body. This binding inhibits the secretion of various hormones, including [[growth hormone]], [[insulin]], and [[glucagon]].

	==~~Medical uses~~==		===Mechanism of Action===
	~~Vapreotide is used in~~ the ~~management of [[acromegaly]]~~, ~~a condition characterized by excessive production~~ of growth hormone~~. It is also employed~~ in ~~the treatment of~~ [[gastrointestinal bleeding~~]] associated with [[esophageal varices]] in patients with [[cirrhosis~~]].		The primary mechanism of action of vapreotide involves its interaction with somatostatin receptors, particularly the SSTR2 and SSTR5 subtypes. By activating these receptors, vapreotide reduces the release of growth hormone and other peptides, which can be beneficial in conditions like acromegaly and [[gastrointestinal bleeding]].

	==~~Mechanism of action~~==		==Medical Uses==
	~~The drug works by mimicking~~ the ~~action~~ of somatostatin, thereby reducing the secretion of various hormones and [[neurotransmitters]]. This action helps in controlling symptoms associated with hormone-secreting tumors and other related conditions.		Vapreotide is used in the management of:

	~~==Side effects==~~		* [[Acromegaly]]: A condition characterized by excessive growth hormone production, leading to enlarged bones and tissues.
	~~Common side effects of vapreotide include~~ [[~~nausea]], [[vomiting~~]], [[~~diarrhea~~]], ~~and~~ [[~~abdominal pain~~]]~~. Long-term use may lead to [[gallstone]] formation due to reduced gallbladder motility~~.		* [[Esophageal varices]]: Dilated veins in the esophagus that can bleed, often associated with [[liver cirrhosis]].

	==~~History~~==		==Administration==
	Vapreotide ~~was developed as part of efforts to create longer-acting~~ and ~~more potent analogs of somatostatin. It has been studied extensively for its potential benefits in treating various endocrine~~ and ~~gastrointestinal disorders~~.		Vapreotide is typically administered via [[intravenous]] or [[subcutaneous injection]]. The dosage and frequency depend on the specific condition being treated and the patient's response to therapy.

	==~~Research~~==		==Side Effects==
	~~Ongoing research is exploring the use~~ of vapreotide ~~in other conditions, such as [[neuroendocrine tumors]] and [[pancreatic cancer]]. Studies are also investigating its efficacy in combination with other therapeutic agents.~~		Common side effects of vapreotide include:

	==Related ~~pages~~==		* [[Nausea]]
			* [[Diarrhea]]
			* [[Abdominal pain]]
			* [[Injection site reactions]]

			==Related Pages==
	* [[Somatostatin]]		* [[Somatostatin]]
	* [[Somatostatin receptor]]		* [[Somatostatin receptor]]
Line 28:		Line 38:
	* [[Esophageal varices]]		* [[Esophageal varices]]

	~~==References==~~		[[Category:Peptide hormones]]
	~~{{Reflist}}~~		[[Category:Somatostatin analogs]]
			[[Category:Endocrinology]]
	[[Category:~~Peptides~~]]
	[[Category:~~Hormones]]~~
	~~[[Category:Antineoplastic and immunomodulating agents~~]]
	[[Category:~~Somatostatin receptor agonists~~]]

Prab: CSV import

2025-02-09T11:56:42Z

CSV import

← Older revision		Revision as of 11:56, 9 February 2025
Line 1:		Line 1:
	'''Vapreotide''' is a synthetic [[somatostatin]] analog ~~that is~~ used in the ~~management~~ of [[~~acromegaly~~]], a ~~rare hormonal disorder~~ that ~~results from an excess~~ of ~~[[growth hormone]]~~ in the body~~. It is also used to treat symptoms associated with [[metastatic]] [[carcinoid tumors]] and vasoactive intestinal peptide secreting tumors (VIPomas)~~.		{{Short description\|Synthetic somatostatin analog}}
			{{Use dmy dates\|date=October 2023}}
			[[File:Vapreotide.svg\|thumb\|Chemical structure of Vapreotide]]
			'''Vapreotide''' is a synthetic [[somatostatin]] analog used primarily in the treatment of certain types of [[cancer]] and [[gastrointestinal]] disorders. It mimics the action of natural somatostatin, a hormone that inhibits the release of several other hormones and secretions in the body.

	== Pharmacology ==		==Pharmacology==
			Vapreotide is a [[cyclic peptide]] that acts as an agonist at somatostatin receptors. It has a high affinity for the [[somatostatin receptor]] subtypes 2, 3, and 5. By binding to these receptors, vapreotide inhibits the secretion of [[growth hormone]], [[insulin]], and [[glucagon]].

	Vapreotide~~, like natural somatostatin, inhibits~~ the ~~secretion~~ of ~~many hormones, including growth hormone,~~ [[~~glucagon~~]], ~~[[insulin]], and [[gastrin]]~~. It ~~does this by binding to somatostatin receptors in the body, which are found~~ in the [[~~pituitary gland~~]]~~, the~~ [[~~pancreas~~]]~~, and certain parts of the~~ [[~~stomach~~]] and [[intestines]]. By binding to these receptors, vapreotide inhibits the release of the aforementioned hormones, thereby helping to control symptoms in conditions where these hormones are overproduced.		==Medical uses==
			Vapreotide is used in the management of [[acromegaly]], a condition characterized by excessive production of growth hormone. It is also employed in the treatment of [[gastrointestinal bleeding]] associated with [[esophageal varices]] in patients with [[cirrhosis]].

	== ~~Clinical Use~~ ==		==Mechanism of action==
			The drug works by mimicking the action of somatostatin, thereby reducing the secretion of various hormones and [[neurotransmitters]]. This action helps in controlling symptoms associated with hormone-secreting tumors and other related conditions.

	~~Vapreotide is used in the treatment~~ of ~~acromegaly, a condition characterized by an overproduction of growth hormone, usually due to a benign tumor in the pituitary gland. By inhibiting the release of growth hormone,~~ vapreotide ~~can help to control the symptoms of this condition~~, ~~which include enlarged hands and feet~~, ~~facial changes~~, and ~~joint~~ pain.		==Side effects==
			Common side effects of vapreotide include [[nausea]], [[vomiting]], [[diarrhea]], and [[abdominal pain]]. Long-term use may lead to [[gallstone]] formation due to reduced gallbladder motility.

	~~In addition, vapreotide is used~~ to ~~manage symptoms associated with metastatic carcinoid tumors~~ and ~~VIPomas~~. ~~These are types of neuroendocrine tumors that can cause a variety of symptoms, including flushing, diarrhea,~~ and ~~wheezing, due to the overproduction of certain hormones. Vapreotide can help to control these symptoms by inhibiting the release of these hormones~~.		==History==
			Vapreotide was developed as part of efforts to create longer-acting and more potent analogs of somatostatin. It has been studied extensively for its potential benefits in treating various endocrine and gastrointestinal disorders.

	== ~~Side Effects~~ ==		==Research==
			Ongoing research is exploring the use of vapreotide in other conditions, such as [[neuroendocrine tumors]] and [[pancreatic cancer]]. Studies are also investigating its efficacy in combination with other therapeutic agents.
	~~Like all medications,~~ vapreotide ~~can cause side effects. The most common side effects include [[nausea]], [[pain]] at the injection site, [[gallstones]], and changes~~ in ~~[[blood sugar]] levels. In rare cases, vapreotide can cause serious side effects~~, such as [[~~heart problems~~]]~~, [[liver problems]],~~ and [[~~allergic reactions~~]].

	~~== See Also ==~~

			==Related pages==
	* [[Somatostatin]]		* [[Somatostatin]]
			* [[Somatostatin receptor]]
	* [[Acromegaly]]		* [[Acromegaly]]
	* [[~~Carcinoid Syndrome~~]]		* [[Esophageal varices]]
	* [[VIPoma]]
			==References==
			{{Reflist}}

	[[Category:~~Drugs~~]]		[[Category:Peptides]]
	[[Category:~~Endocrinology~~]]		[[Category:Hormones]]
	[[Category:~~Pharmacology~~]]		[[Category:Antineoplastic and immunomodulating agents]]
	~~{{Pharma-stub}}~~		[[Category:Somatostatin receptor agonists]]

Prab: CSV import

2024-03-02T17:19:01Z

CSV import

New page

'''Vapreotide''' is a synthetic [[somatostatin]] analog that is used in the management of [[acromegaly]], a rare hormonal disorder that results from an excess of [[growth hormone]] in the body. It is also used to treat symptoms associated with [[metastatic]] [[carcinoid tumors]] and vasoactive intestinal peptide secreting tumors (VIPomas).

== Pharmacology ==

Vapreotide, like natural somatostatin, inhibits the secretion of many hormones, including growth hormone, [[glucagon]], [[insulin]], and [[gastrin]]. It does this by binding to somatostatin receptors in the body, which are found in the [[pituitary gland]], the [[pancreas]], and certain parts of the [[stomach]] and [[intestines]]. By binding to these receptors, vapreotide inhibits the release of the aforementioned hormones, thereby helping to control symptoms in conditions where these hormones are overproduced.

== Clinical Use ==

Vapreotide is used in the treatment of acromegaly, a condition characterized by an overproduction of growth hormone, usually due to a benign tumor in the pituitary gland. By inhibiting the release of growth hormone, vapreotide can help to control the symptoms of this condition, which include enlarged hands and feet, facial changes, and joint pain.

In addition, vapreotide is used to manage symptoms associated with metastatic carcinoid tumors and VIPomas. These are types of neuroendocrine tumors that can cause a variety of symptoms, including flushing, diarrhea, and wheezing, due to the overproduction of certain hormones. Vapreotide can help to control these symptoms by inhibiting the release of these hormones.

== Side Effects ==

Like all medications, vapreotide can cause side effects. The most common side effects include [[nausea]], [[pain]] at the injection site, [[gallstones]], and changes in [[blood sugar]] levels. In rare cases, vapreotide can cause serious side effects, such as [[heart problems]], [[liver problems]], and [[allergic reactions]].

== See Also ==

* [[Somatostatin]]
* [[Acromegaly]]
* [[Carcinoid Syndrome]]
* [[VIPoma]]

[[Category:Drugs]]
[[Category:Endocrinology]]
[[Category:Pharmacology]]
{{Pharma-stub}}